$EXOZ 4 SEC Filings

Filed On	Filing
26 Oct 2026	Form 4: Perriman Damien Alan, Chief Commercial Officer Received 3,922 shares by exercise or conversion · Sold 3,729 shares ($19.4K)
19 Oct 2026	Form 4: Rayo Edgardo Javier, Director Granted 25,000 Stock Option (right to buy)
19 Oct 2026	Form 4: Marlett Christopher A, Director Granted 10,000 Stock Option (right to buy)
19 Oct 2026	Form 4: Lalonde James Joseph, Director Granted 10,000 Stock Option (right to buy)
19 Oct 2026	Form 4: Digiandomenico Anthony, Director Granted 10,000 Stock Option (right to buy)
19 Oct 2026	Form 4: Bowie James Ulrich, Director Granted 10,000 Stock Option (right to buy)
19 Oct 2026	Form 4: Bell Lon E, Director Granted 10,000 Stock Option (right to buy)
17 Sep 2026	Form 4: Nawaz Fouad, Vice President- Finance Granted 45,000 Stock Option (right to buy)
02 Sep 2026	Form 4: Heltzen Michael, Chief Executive Officer Received 8,841 shares as a grant or award ($56.6K) · Bought 350 shares ($2.63K) · Bought 505 shares ($3.78K)
25 Aug 2026	Form 4: Perriman Damien Alan, Chief Commercial Officer Received 19,612 shares by exercise or conversion
25 Aug 2026	Form 4: Korman Tyler Paz, Chief Scientific Officer Received 32,964 shares by exercise or conversion
10 Apr 2026	Form 4: Korman Tyler Paz, Chief Scientific Officer Sold 750 shares ($7.53K) · Sold 750 shares ($7.89K)
08 Apr 2026	Form 4: Perriman Damien Alan, Chief Commercial Officer Received 62,759 shares as a grant or award · Granted 146,437 Stock Option for Common Stock
08 Apr 2026	Form 4: Perriman Damien Alan, Chief Commercial Officer Received 8,887 shares as a grant or award ($75K)
08 Apr 2026	Form 4: Opgenorth Paul Hideo, Vice President, Development Received 3,999 shares as a grant or award ($33.8K)
08 Apr 2026	Form 4: Nawaz Fouad, Vice President- Finance Received 5,999 shares as a grant or award ($50.6K)
08 Apr 2026	Form 4: Korman Tyler Paz, Chief Scientific Officer Received 5,332 shares as a grant or award ($45K)
02 Jul 2025	Form 4: Heltzen Michael, Chief Executive Officer Bought 1,040 shares ($10.6K)
20 Jun 2025	Form 4: Heltzen Michael, Chief Executive Officer Granted 235,817 Stock Options for Common Stock
17 Jun 2025	Form 4: Korman Tyler Paz, Vice President, Research Received 2,990 shares as a grant or award ($37.5K)

Comments